Cizzle Biotechnology Holdings Plc (LON:CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.476
+0.076 (5.43%)
Sep 5, 2025, 4:18 PM BST
5.43%
Market Cap5.55M
Revenue (ttm)n/a
Net Income (ttm)-2.17M
Shares Out396.39M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume422,020
Average Volume2,959,159
Open1.300
Previous Close1.400
Day's Range1.300 - 1.500
52-Week Range1.200 - 2.690
Beta0.59
RSI54.22
Earnings DateSep 26, 2025

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.